7Baggers
 IMNM Analyst Rating Update: Stephens & Co. Raises Price Target |  GuruFocus Mon, 17 Nov 2025 13:35:23 GMT
 Immunome price target raised to $33 from $25 at Stephens  TipRanks Mon, 17 Nov 2025 12:40:11 GMT
 Immunome stock hits 52-week high at 17.89 USD By Investing.com  Investing.com Canada Thu, 13 Nov 2025 06:41:12 GMT
 Immunome stock hits 52-week high at 17.89 USD  Investing.com Wed, 12 Nov 2025 15:30:07 GMT
 immunome stock hits 52-week high at 17.89 usd by investing.com  Investing.com Australia Wed, 12 Nov 2025 14:50:11 GMT
 Immunome, Inc. Reports Q3 2025 Financial Results  TipRanks Tue, 11 Nov 2025 04:40:02 GMT
 IMNM December 2026 Options Begin Trading  Nasdaq Fri, 07 Nov 2025 16:02:00 GMT
 Immunome Stays Confident Despite Heavy Losses And Bold Spending  Finimize Fri, 07 Nov 2025 12:12:11 GMT
 insider stock buying reaches us$3.74m on immunome  Yahoo Finance UK Fri, 07 Nov 2025 10:15:02 GMT
 Decoding Immunome Inc (IMNM): A Strategic SWOT Insight  GuruFocus Fri, 07 Nov 2025 05:22:16 GMT
 Immunome reports Q3 EPS (65c), consensus (54c)  TipRanks Thu, 06 Nov 2025 21:00:00 GMT
 Immunome Stock Hits Day Low of $14.71 Amid Price Pressure  Markets Mojo Thu, 06 Nov 2025 19:10:43 GMT
 immunome (nasdaq:imnm) shares up 7.7% - should you buy?  MarketBeat Tue, 04 Nov 2025 20:59:25 GMT
 immunome stock hits 52-week high at 17.34 usd by investing.com  Investing.com Philippines Tue, 04 Nov 2025 19:12:25 GMT
 immunome (nasdaq:imnm) reaches new 12-month high - still a buy?  MarketBeat Tue, 04 Nov 2025 10:20:05 GMT
 Immunome stock hits 52-week high at 17.34 USD By Investing.com  Investing.com Canada Mon, 03 Nov 2025 18:33:45 GMT
 Immunome stock hits 52-week high at 17.34 USD  Investing.com Mon, 03 Nov 2025 08:00:00 GMT
 Immunome, Inc. Hits New 52-Week High of $17.87  Markets Mojo Mon, 03 Nov 2025 08:00:00 GMT
 Immunome Bets Big On Cancer Drugs As Shares Outpace The Market  Finimize Fri, 31 Oct 2025 03:28:54 GMT
 immunome bets big on cancer drugs as shares outpace the market  Finimize Thu, 30 Oct 2025 12:21:27 GMT
 immunome (nasdaq:imnm) trading 8.3% higher - time to buy?  MarketBeat Tue, 28 Oct 2025 07:00:00 GMT
 Immunome’s Phase 1 Cancer Study: A Potential Game-Changer?  TipRanks Mon, 27 Oct 2025 07:00:00 GMT
 immunome's (imnm) sell (d-) rating reiterated at weiss ratings  MarketBeat Sun, 26 Oct 2025 07:00:00 GMT

Immunome, Inc
(NASDAQ:IMNM) 

IMNM stock logo

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also devel...

Founded: 2006
CEO: Purnanand D. Sarma  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends